Plasma biomarkers predict deterioration in cognitively normal elderly adults
Plasma concentrations of the biomarkers amyloid-β (Aβ) 42/40, phospho-tau217 (P-tau217), and neurofilament light (NfL) could help predict deterioration in cognitively unimpaired elderly adults, a recent study has found.